Hosted on MSN1mon
Novartis agrees to acquire Anthos for up to $3.1 billion
Anthos is conducting several phase 3 clinical studies, with data from these trials expected in the second half of 2026, Blackstone said. Reuters reported in December 2023 that Blackstone was ...
Morningstar1mon
Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 Billion
Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company”), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the ...
CRN4y
Google Cloud’s Anthos on AWS Now Generally Available
Anthos on Microsoft Azure is being tested with customers. Google Cloud, which continues to boost the capabilities of its hybrid and multi-cloud Anthos platform, today announced the general ...
CRN4y
Google Cloud Set To Announce GA Of Anthos On AWS
Google Cloud also will disclose that Anthos on Microsoft Azure is being tested with customers and Anthos support for virtual machines is in early preview with customers. Google Cloud, which ...
PE Hub1mon
Blackstone sells Anthos to Novartis for up to $3.1bn
Blackstone Life Sciences has sold Anthos Therapeutics to Novartis for up to $3.1 billion. Anthos is a transformative, clinical-stage biopharmaceutical company developing innovative therapies for ...